Paysign (NASDAQ:PAYS) Coverage Initiated at Lake Street Capital

Lake Street Capital began coverage on shares of Paysign (NASDAQ:PAYS - Get Free Report) in a report issued on Friday, MarketBeat Ratings reports. The firm set a "buy" rating and a $6.00 price target on the stock. Lake Street Capital's price objective indicates a potential upside of 100.67% from the company's current price.

Separately, Barrington Research reaffirmed an "outperform" rating and set a $7.00 price objective on shares of Paysign in a research report on Monday, November 4th. Four equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Paysign presently has a consensus rating of "Buy" and a consensus target price of $6.13.

Paysign Price Performance

Shares of NASDAQ PAYS traded up $0.06 during midday trading on Friday, hitting $2.99. The company's stock had a trading volume of 347,591 shares, compared to its average volume of 243,970. The firm has a market capitalization of $160.11 million, a price-to-earnings ratio of 19.93 and a beta of 0.93. The business's fifty day simple moving average is $3.52 and its two-hundred day simple moving average is $4.07. Paysign has a 1 year low of $2.40 and a 1 year high of $5.59.

Paysign (NASDAQ:PAYS - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.02. The business had revenue of $15.26 million during the quarter, compared to analysts' expectations of $14.96 million. Paysign had a return on equity of 30.64% and a net margin of 14.28%. During the same quarter last year, the business posted $0.02 EPS. Analysts anticipate that Paysign will post 0.21 EPS for the current fiscal year.

Insider Activity at Paysign

In other news, insider Matthew Louis Lanford sold 25,360 shares of Paysign stock in a transaction on Friday, November 8th. The shares were sold at an average price of $3.96, for a total value of $100,425.60. Following the transaction, the insider now directly owns 109,731 shares of the company's stock, valued at $434,534.76. The trade was a 18.77 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Mark Newcomer sold 50,000 shares of the stock in a transaction on Monday, September 23rd. The stock was sold at an average price of $4.25, for a total transaction of $212,500.00. Following the sale, the chief executive officer now owns 9,486,886 shares of the company's stock, valued at approximately $40,319,265.50. This represents a 0.52 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 339,360 shares of company stock valued at $1,234,246 in the last ninety days. Insiders own 23.40% of the company's stock.

Institutional Investors Weigh In On Paysign

A number of institutional investors and hedge funds have recently made changes to their positions in PAYS. Sanctuary Advisors LLC increased its position in Paysign by 4.3% in the 3rd quarter. Sanctuary Advisors LLC now owns 121,089 shares of the company's stock valued at $419,000 after acquiring an additional 5,000 shares during the period. Barclays PLC grew its stake in shares of Paysign by 327.4% in the 3rd quarter. Barclays PLC now owns 47,090 shares of the company's stock valued at $173,000 after purchasing an additional 36,071 shares during the last quarter. BNP Paribas Financial Markets increased its holdings in shares of Paysign by 257.0% in the third quarter. BNP Paribas Financial Markets now owns 44,793 shares of the company's stock valued at $164,000 after purchasing an additional 32,245 shares during the period. Bard Associates Inc. purchased a new stake in shares of Paysign during the third quarter worth approximately $103,000. Finally, Royce & Associates LP acquired a new stake in shares of Paysign during the third quarter worth $814,000. 25.89% of the stock is owned by hedge funds and other institutional investors.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.